Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy
Last updated on April 2022Recruitment
- Recruitment Status
- Recruiting
Inclusion Criteria
- diabetic patients requiring opthalmologic treatments for different degrees of decreasing of visual acuity.
- age over 20 years
- nondiabetic patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
- ...
- diabetic patients requiring opthalmologic treatments for different degrees of decreasing of visual acuity.
- age over 20 years
- nondiabetic patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
- diabetic patients requiring intravitreal injection,cataract surgery or vitrectomy
Exclusion Criteria
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
- patients that did not signed the informed consent of the trial
- patients with recent ocular trauma
- ...
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
- patients that did not signed the informed consent of the trial
- patients with recent ocular trauma
- under the age of 20 years
- patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
Summary
- Conditions
- Diabetic Retinopathy
- Type
- Observational
- Design
- Observational Model: Case-Control
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 20 years and 80 years
- Gender
- Both males and females
Description
This prospective, case-control study included 50 patients(50eyes) with severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy and 50 patient with nondiabetic retinopathy or cataract. Aqueous humor was taken before injection of anti-vascular endothelial growth factor agent...
This prospective, case-control study included 50 patients(50eyes) with severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy and 50 patient with nondiabetic retinopathy or cataract. Aqueous humor was taken before injection of anti-vascular endothelial growth factor agent or pars plana vitrectomy for other retinal disease. Angiogenic and non-angiogenic proteins were analyzed.
Inclusion Criteria
- diabetic patients requiring opthalmologic treatments for different degrees of decreasing of visual acuity.
- age over 20 years
- nondiabetic patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
- ...
- diabetic patients requiring opthalmologic treatments for different degrees of decreasing of visual acuity.
- age over 20 years
- nondiabetic patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
- diabetic patients requiring intravitreal injection,cataract surgery or vitrectomy
Exclusion Criteria
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
- patients that did not signed the informed consent of the trial
- patients with recent ocular trauma
- ...
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
- patients that did not signed the informed consent of the trial
- patients with recent ocular trauma
- under the age of 20 years
- patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
Tracking Information
- NCT #
- NCT02026843
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Dong Ho Park, M.D Kyungpook National University Hospital
- Dong Ho Park, M.D Kyungpook National University Hospital